Clinical study of ZiYu Prescription in the treatment of polycystic ovary syndrome

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) It meets the diagnostic criteria of Western medicine for polycystic ovary syndrome and the diagnostic criteria of traditional Chinese medicine for renal deficiency;
•(2) Between the ages of 18 and 40.
•(3) Have not taken any drugs that affect menstruation (such as contraceptives, hormones or other drugs that affect insulin, blood glucose, sex hormones and lipid metabolism) within 3 months and have not used relevant treatment methods, and have no record of induced abortion;
•(4) Gynecological examination and auxiliary examination: there are no organic lesions of internal and external genitalia, and there are no other primary diseases;
•(5) Sign the patient's informed consent form.

•(1) The presence of congenital deficiencies in the patient's reproductive system cannot meet the needs of this study.
•(2) The patient has a congenital inherited mental illness.
•(3) The patient's liver, heart, kidney, hematopoietic system and other human organ functions are failed.
•(4) The patient has a special physique and has a history of serious allergies to the drug.
•(5) Patients who cannot be performed according to this study protocol.
•(6) Patients with other diseases need to undergo other aspects of treatment, and patients who may have an impact on this study.
•(7) Pregnant or lactating women.

发起方

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine